IGF-1R targeting in cancer – does sub-cellular localization matter?
Abstract The insulin-like growth factor receptor (IGF-1R) was among the most intensively pursued kinase targets in oncology. However, even after a slew of small-molecule and antibody therapeutics reached clinical trials for a range of solid tumors, the initial promise remains unfulfilled. Mechanisms...
Main Authors: | Upendra K. Soni, Liam Jenny, Rashmi S. Hegde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13046-023-02850-7 |
Similar Items
-
Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
by: Yinqi Zhang, et al.
Published: (2021-11-01) -
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
by: Hesham M. Amin, et al.
Published: (2020-07-01) -
The Role of IGF/IGF-IR-Signaling and Extracellular Matrix Effectors in Bone Sarcoma Pathogenesis
by: George N. Tzanakakis, et al.
Published: (2021-05-01) -
Elevated serum concentrations of IGF-1 and IGF-1R in patients with thyroid cancers
by: Hanna Lawnicka, et al.
Published: (2020-03-01) -
IGF2/IGF1R Signaling as a Therapeutic Target in MYB-Positive Adenoid Cystic Carcinomas and Other Fusion Gene-Driven Tumors
by: Mattias K. Andersson, et al.
Published: (2019-08-01)